Hawaii 2023 Regular Session

Hawaii House Bill HB573

Introduced
1/23/23  
Refer
1/27/23  
Report Pass
3/2/23  
Engrossed
3/3/23  
Refer
3/9/23  
Report Pass
3/23/23  

Caption

Relating To Fentanyl Test Strips.

Impact

If passed, HB573 would have a significant impact on drug-related policies in Hawaii by facilitating easier access to fentanyl test strips. This amendment is seen as a positive step towards accommodating harm reduction strategies and fostering a public health approach to drug use. The proposed legislation is in line with efforts worldwide to combat the surge in overdose deaths attributed to fentanyl and aims to lessen stigma associated with drug use by supporting preventive measures.

Summary

House Bill 573 seeks to amend the definition of drug paraphernalia under Hawaii Revised Statutes to explicitly exclude fentanyl test strips from this classification. By doing so, the bill acknowledges the importance of these strips as a potential harm reduction tool amidst the growing concern over fentanyl-related overdose deaths. The measure aims to encourage their use among individuals who might be at risk of consuming tainted substances containing fentanyl, potentially saving lives by allowing users to test their drugs for the presence of this dangerous opioid.

Sentiment

The sentiment around HB573 is generally positive among health advocates, public health officials, and those focused on harm reduction. They argue that the availability of fentanyl test strips is a proactive approach to addressing the opioid crisis. However, there may be concerns from certain segments of the community regarding the implications of normalizing or promoting drug use through the provision of such testing tools, which could influence the overall stance on addiction and treatment options.

Contention

Notably, discussions surrounding the bill may highlight a tension between harm reduction advocates and those who prioritize strict drug enforcement measures. Supporters of the bill view it as a necessary measure to prevent overdoses, while opponents could argue that it may inadvertently encourage drug use. Additionally, defining fentanyl test strips explicitly in law underscores their role as a public health tool rather than an endorsement of drug use, which is crucial in navigating the contentious landscape of substance use policy.

Companion Bills

No companion bills found.

Similar Bills

HI HB573

Relating To Fentanyl Test Strips.

HI SB671

Relating To Health.

HI HB2086

Relating To Health.

HI SB2749

Relating To Health.

KS HB2398

Adding the placing of controlled substances into pills into the definition of manufacture, increasing the criminal penalties for manufacturing fentanyl and creating a special sentencing rule to make sentences for distributing fentanyl presumptive imprisonment.

KS HB2328

Excluding tests to detect the presence of fentanyl, ketamine or gamma hydroxybutyric acid in a substance from the definition of drug paraphernalia.

KS SB238

Increasing criminal penalties on drug-related crimes when the drug is fentanyl and creating special sentencing rules for mandatory imprisonment and additional terms of imprisonment for drug-related crimes when the drug is fentanyl or is attractive to minors because of its appearance or packaging.

MS HB838

Uniform Controlled Substances Law; exclude hypodermic syringes from definition of paraphernalia.